Skip to main content
Premium Trial:

Request an Annual Quote

Fisher Scientific to Distribute Response Bio's Ramp Cardiac Product in Canada

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fisher Scientific will exclusively distribute Response Biomedical's RAMP cardiac products in Canada under a deal announced today.

Financial and other terms of the agreement were not disclosed.

Fisher Scientific is part of Thermo Fisher Scientific.

According to Vancouver, British Columbia-based Response Biomedical, point-of-care testing in Canada is projected to reach C$63 million ($66.2 million) this year with an estimated growth rate of 7 percent over the next few years.

Response Bio's RAMP system consists of a reader and single-use disposable test cartridges. RAMP clinical tests are commercially available for the early detection of heart attack and congestive heart failure.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.